These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24598781)

  • 21. Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation.
    Blondel S; Egesipe AL; Picardi P; Jaskowiak AL; Notarnicola M; Ragot J; Tournois J; Le Corf A; Brinon B; Poydenot P; Georges P; Navarro C; Pitrez PR; Ferreira L; Bollot G; Bauvais C; Laustriat D; Mejat A; De Sandre-Giovannoli A; Levy N; Bifulco M; Peschanski M; Nissan X
    Cell Death Dis; 2016 Feb; 7(2):e2105. PubMed ID: 26890144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.
    Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An encouraging progress report on the treatment of progeria and its implications for atherogenesis.
    Oshima J; Hisama FM; Martin GM
    Circulation; 2014 Jul; 130(1):4-6. PubMed ID: 24795391
    [No Abstract]   [Full Text] [Related]  

  • 24. Dysfunction of iPSC-derived endothelial cells in human Hutchinson-Gilford progeria syndrome.
    Matrone G; Thandavarayan RA; Walther BK; Meng S; Mojiri A; Cooke JP
    Cell Cycle; 2019 Oct; 18(19):2495-2508. PubMed ID: 31411525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment.
    Columbaro M; Capanni C; Mattioli E; Novelli G; Parnaik VK; Squarzoni S; Maraldi NM; Lattanzi G
    Cell Mol Life Sci; 2005 Nov; 62(22):2669-78. PubMed ID: 16261260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prelamin A accumulation in endothelial cells induces premature senescence and functional impairment.
    Bonello-Palot N; Simoncini S; Robert S; Bourgeois P; Sabatier F; Levy N; Dignat-George F; Badens C
    Atherosclerosis; 2014 Nov; 237(1):45-52. PubMed ID: 25200614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery.
    Lo Cicero A; Nissan X
    Ageing Res Rev; 2015 Nov; 24(Pt B):343-8. PubMed ID: 26474742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells.
    Cao K; Graziotto JJ; Blair CD; Mazzulli JR; Erdos MR; Krainc D; Collins FS
    Sci Transl Med; 2011 Jun; 3(89):89ra58. PubMed ID: 21715679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A.
    Musich PR; Zou Y
    Aging (Albany NY); 2009 Jan; 1(1):28-37. PubMed ID: 19851476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated.
    Yang SH; Andres DA; Spielmann HP; Young SG; Fong LG
    J Clin Invest; 2008 Oct; 118(10):3291-300. PubMed ID: 18769635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of musculoskeletal phenotype of the G608G progeria mouse model with lonafarnib, pravastatin, and zoledronic acid as treatment groups.
    Cubria MB; Suarez S; Masoudi A; Oftadeh R; Kamalapathy P; DuBose A; Erdos MR; Cabral WA; Karim L; Collins FS; Snyder BD; Nazarian A
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12029-12040. PubMed ID: 32404427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
    Finley J
    Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape.
    Chen Z; Chang WY; Etheridge A; Strickfaden H; Jin Z; Palidwor G; Cho JH; Wang K; Kwon SY; Doré C; Raymond A; Hotta A; Ellis J; Kandel RA; Dilworth FJ; Perkins TJ; Hendzel MJ; Galas DJ; Stanford WL
    Aging Cell; 2017 Aug; 16(4):870-887. PubMed ID: 28597562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin.
    Wang Y; Panteleyev AA; Owens DM; Djabali K; Stewart CL; Worman HJ
    Hum Mol Genet; 2008 Aug; 17(15):2357-69. PubMed ID: 18442998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hutchinson-Gilford progeria syndrome through the lens of transcription.
    Prokocimer M; Barkan R; Gruenbaum Y
    Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA.
    Nissan X; Blondel S; Navarro C; Maury Y; Denis C; Girard M; Martinat C; De Sandre-Giovannoli A; Levy N; Peschanski M
    Cell Rep; 2012 Jul; 2(1):1-9. PubMed ID: 22840390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria.
    Nissan X; Blondel S; Peschanski M
    Biochem Soc Trans; 2011 Dec; 39(6):1775-9. PubMed ID: 22103524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the efficacy of protein farnesyltransferase inhibitors in mouse models of progeria.
    Yang SH; Chang SY; Andres DA; Spielmann HP; Young SG; Fong LG
    J Lipid Res; 2010 Feb; 51(2):400-5. PubMed ID: 19965595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells.
    Atchison L; Zhang H; Cao K; Truskey GA
    Sci Rep; 2017 Aug; 7(1):8168. PubMed ID: 28811655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapamycin activates autophagy in Hutchinson-Gilford progeria syndrome: implications for normal aging and age-dependent neurodegenerative disorders.
    Graziotto JJ; Cao K; Collins FS; Krainc D
    Autophagy; 2012 Jan; 8(1):147-51. PubMed ID: 22170152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.